Ginkgo Bioworks director granted 25,000 RSUs
SLOAN HARRY reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
SLOAN HARRY reported acquisition or exercise transactions in this Form 4 filing.
Ginkgo Bioworks Holdings, Inc. director Harry Sloan received a grant of 25,000 restricted stock units on June 11, 2026. Each RSU represents a right to receive one share of Class A common stock. The RSUs vest on the earlier of June 11, 2027 or the day before the next annual meeting, if he continues serving as a non-employee director.
Insider Trade Summary
Grant/Award: 25,000 shares
Grant/Award
1 txn
Insider
SLOAN HARRY
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 25,000 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 25,000 contracts (Direct)
Footnotes (2)
- F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- F2. In accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Program, which became effective on June 11, 2026, the RSUs shall vest on the earlier of June 11, 2027 or the day immediately prior to the date of the next Annual Meeting occurring after the date of grant, in either case, subject to the Reporting Person continuing in service as a Non-Employee Director through such vesting date.
Key Figures
RSUs granted: 25,000 RSUs
Shares underlying RSUs: 25,000 shares
Exercise price: $0.00 per share
+1 more
4 metrics
RSUs granted
25,000 RSUs
Grant to director Harry Sloan on June 11, 2026
Shares underlying RSUs
25,000 shares
Class A common stock underlying the RSU award
Exercise price
$0.00 per share
RSU grant has no cash exercise price
Vesting date
June 11, 2027
Earlier of June 11, 2027 or day before next annual meeting
Key Terms
Restricted Stock Units, Class A Common Stock, Non-Employee Director Compensation Program, vesting
4 terms
Restricted Stock Units financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Class A Common Stock financial
"to receive one share of the Issuer's Class A Common Stock"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
Non-Employee Director Compensation Program financial
"In accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Program"
vesting financial
"the RSUs shall vest on the earlier of June 11, 2027 or the day immediately prior"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Ginkgo Bioworks (DNA) report for Harry Sloan?
Harry Sloan received a grant of 25,000 restricted stock units from Ginkgo Bioworks. These RSUs are a form of equity compensation and give him the right to receive the same number of Class A common shares upon vesting, subject to service conditions.
When do Harry Sloan’s 25,000 RSUs at Ginkgo Bioworks (DNA) vest?
The 25,000 RSUs vest on the earlier of June 11, 2027 or the day immediately before the next annual shareholder meeting. Vesting requires Harry Sloan to continue serving as a non-employee director through the applicable vesting date under the company’s director compensation program.
What does each RSU granted to Harry Sloan by Ginkgo Bioworks (DNA) represent?
Each restricted stock unit represents a contingent right to receive one share of Ginkgo Bioworks’ Class A common stock. The shares are only delivered if the vesting conditions are satisfied, linking director compensation to the company’s equity over time.
How many Ginkgo Bioworks (DNA) RSUs does Harry Sloan hold after this Form 4?
After this reported transaction, Harry Sloan holds 25,000 restricted stock units directly. These RSUs were granted at no cash cost and will convert into an equivalent number of Class A common shares if the specified vesting requirements are met.
Is Harry Sloan’s RSU grant from Ginkgo Bioworks (DNA) an open-market purchase or sale?
The RSU grant is not an open-market purchase or sale. It is a compensation-related award recorded as an acquisition on the Form 4, with zero exercise price, reflecting equity granted under the non-employee director compensation program rather than a market trade.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates